Overview

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Status:
Terminated
Trial end date:
2020-01-30
Target enrollment:
Participant gender:
Summary
A randomized open-label study of fixed-dose versus concentration-controlled mycophenolate mofetil for treatment of active lupus nephritis.
Phase:
Phase 4
Details
Lead Sponsor:
Chulalongkorn University
Collaborator:
Berlin Pharmaceutical Industry
Treatments:
Mycophenolic Acid